Join our newsletter! 
Emerald Health Pharmaceuticals (EHP) is making great strides in the discovery, development and commercialization of proprietary cannabinoid-derived medicines that address significant unmet needs. Sign up below to receive the latest news from EHP, including press releases, product development, scientific publications, events and financial reporting directly to your inbox.

Emerald Health Pharmaceuticals is a member of the Emerald Group, which comprises multiple companies focused on developing pharmaceutical, botanical, and nutraceutical products providing wellness and medical benefits by interacting with the human body’s endocannabinoid system.
* indicates required